Journal
MULTIPLE SCLEROSIS JOURNAL
Volume 10, Issue -, Pages S62-S62Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1191/1352458504ms1033oa
Keywords
primary progressive MS; interferon beta-1b; MRI; EDSS; MSFC
Categories
Ask authors/readers for more resources
This short monograph describes a trial of interferon beta-1b in patients with primary progressive multiple sclerosis (PPMS) or transitional MS. Designed as a randomized, placebo-controlled pilot, the trial randomly placed 73 eligible patients into two groups, placebo or interferon beta-1b 8 MIU given subcutaneously every other day for two years. Significant differences favouring interferon beta-1b in the MSFC score, T2 lesion volume and T1 lesion volume at 24 months were observed. Further study of interferon beta-1b therapy in PPMS patients is warranted.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available